Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

with US$30 million already funded in January 2013.

[7] All multiples referenced in this section are as at February 22, 2013, being the last trading day prior to the Proposal Announcement.

[8] Based on I/B/E/S consensus for earnings per share forecasts and share prices both downloaded from FactSet on February 22, 2013.

[9] Based on I/B/E/S consensus for earnings per share forecasts and share prices both downloaded from FactSet on February 22, 2013.

[10] Calculation assumes that US$5 is distributed to each Elan Shareholder (which implies a total cash distribution of US$3.0 billion based on 602.0 million fully diluted shares in issue at the Proposal Price) and that there is no impact of cash distribution on 2015E Broker Projected Earnings Per Share.

[11] Sourced from CallStreet transcript of the Tysabri Conference Call.

[12] Royalty Pharma has underscored certain portions of the passages for emphasis.

[13] Sourced from equity research reports published by RBC Capital Markets and Deutsche Bank on March 4, 2013.

[14] Sourced from Reuters article published March 4, 2013 titled, "Elan offers special dividend to fend off Royalty" and Bloomberg article published March 4, 2013.

[15] Based on broker notes released after the announcement of the Tysabri Transaction and prior to February 25, 2013

[16] Comments made in notes by Berenberg Bank, Davy, Deutsche Bank, Exane BNP Paribas, Leerink Swann, Morgan Stanley, RBC Capital Markets and UBS released after the announcement of the Tysabri Transaction and prior to February 25, 2013.

[17] Comments made in notes by Leerink Swann, RBC Capital Markets and UBS released after the announcement of the Tysabri Transaction and prior to February 25, 2013.

[18] Calculated in Appendix VI.

[19] Sourced from the Biogen presentation made to investors on February 6, 2013 which states on slide 13 that "Asset Purchase Structure Enables: Approximately US$30M in a
'/>"/>

SOURCE RP Management, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
2. Cowen Healthcare Royalty Partners Raises $1 Billion
3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
6. AVANIR Pharmaceuticals To participate in two conferences in March
7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  David Hardison, Ph.D., vice president ... , has been elected chairman of the board ... non-profit working to establish common protocols around the ... relates to electronic health records. ... collaborating with organizations across the research and health ...
(Date:7/28/2014)... 28, 2014 The global market for ... 2020, according to a new study by Grand View ... demand for effective vaccines and drugs in an attempt ... needs is expected to drive market demand over the ... agricultural productivity via the use of genetically engineered seeds ...
(Date:7/26/2014)... 2014 Canada Endoscopy Visualization Systems ... on the Canada Endoscopy Visualization Systems market. The ... volume (in units) and average prices (in US ... Systems, Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy ... http://www.marketresearchreports.biz/analysis/213254 . , The report also provides company ...
(Date:7/25/2014)... 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... Metabolomics or Metabonomics is the scientific study of ... new experimental technique that is being widely used ... are small molecules that are present in blood, ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , ... company, announced the resignation of Greg Peet from ... Mr. Peet has resigned,to enable him to focus ... Mr. Peet has served on Angiotech,s Board of ...
... April 15 Vion,Pharmaceuticals, Inc. (Nasdaq: VION ) ... and sustain compliance with The Nasdaq Capital Market,listing requirements, ... Previously, the Company announced that it had received ... Market, Inc., notifying the Company,that it does not comply ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX: ONC, NASDAQ: ONCY) ... of the Tom Baker Cancer Centre, Calgary, entitled,"Targeting ... at the American Association for Cancer Research (AACR) ... Diego, California from April,12-16, 2008., The presentation ...
Cached Biology Technology:Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting 2
(Date:7/28/2014)... disease and other forms of dementia, but the research ... University of Washington bioengineers have a designed a peptide ... body,s normal proteins into a state that,s linked to ... 2 diabetes and Lou Gehrig,s disease. The synthetic molecule ... state into an abnormally folded form by targeting a ...
(Date:7/28/2014)... identified areas of the Earth that are high priorities ... Europe is particularly vulnerable, as it has the lowest ... of any continent in ,refugia, areas of biological ... remain relatively constant during times of great environmental change. ... in Scandinavia and Scotland. , The biggest refugia ...
(Date:7/28/2014)... Research Hospital study found that 73 percent of adult ... of developing metabolic syndrome and related health problems by ... in the current issue of the journal Cancer ... survivors of childhood cancer in the study had metabolic ... high blood pressure, abdominal obesity, elevated triglyceride and other ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3
... University of Alaska Fairbanks scientist Michael Whalen is part of ... swath of evidence striking a definitive blow in the ongoing ... published in the March 5 issue of the journal ... that an asteroid ended the age of the dinosaurs. ...
... microbial genomes have been sequenced at various sequencing centers ... roles in tasks ranging from bioenergy to health to ... will be publicly available within the next two years, ... technological advances that have made the sequencing process faster ...
... Researchers working with Professor Gudrun Rappold, Director of ... Hospital, have discovered previously unknown mutations in autistic and ... SHANK2 gene, a gene that is partially responsible for ... not always enough to trigger the illness. In some ...
Cached Biology News:Scientists conclude asteroid ended the age of dinosaurs 2DOE JGI produces new QC tool for microbial genomes 2DOE JGI produces new QC tool for microbial genomes 3DOE JGI produces new QC tool for microbial genomes 4Newly discovered gene variants lead to autism and mental retardation 2
... 100 g of monoclonal antibody reactive against ... of SURF1 are highest in growing cultured cells. ... c oxidase which is thought to participate in ... insertion into this subunit. Mutations of SURF1, particularly ...
... (Thr183/Tyr185) Antibody Kit Kit Includes: ... #9251, 200 ul SAPK/JNK (56G8) Rabbit ... Cell Extracts, Catalog #9253, (4 Western ... #7074, 100 ul Anti-biotin IgG, HRP-linked ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Biology Products: